Tuesday, June 16, 2026

Rivian Shares Surge 4% Following Electric Van Launch and Expansion of Orders

Rivian's stock rose 4% after launching its electric van and ending exclusivity with Amazon, allowing new deals with other companies.

Peaceful Time is Over: Is Coexistence the New Path for South Korea?

Experts urge South Korea to shift from unification to coexistence with North Korea, focusing on practical peace amid rising tensions.

aespa Sweeps MTV Japan Awards — First Female Act to Win 4 Titles

aespa shines at VMAJ 2025, winning four major awards, including Artist of the Year, solidifying their global music influence.

Tag: CAR-T therapy

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Korea’s First Domestic CAR-T Therapy Just Won Approval—and That’s a Bigger Deal Than It Sounds

CureCell's CAR-T therapy Rimkato is the first approved in South Korea, enhancing access to treatment for blood cancer patients.

Curocell’s RIMQARTO®: The First CAR-T Therapy in Korea, with Plans for Global Release

Curocell aims to lead in CAR-T therapies with RIMQARTO's approval, focusing on solid tumors and global expansion strategies.

Verismo unveils preclinical data on improved antitumor efficacy and safety of blood cancer CAR-T at AACR

HLB Innovation's SynKIR-310 shows improved antitumor activity and safety in preclinical trials, achieving 100% survival in mice.

Revolutionary CAR-T Treatment SynKIR-310 Outperforms CD19 CAR-T: What This Means for Blood Cancer Patients

Verismo Therapeutics' SynKIR-310 shows superior anti-tumor effects in preclinical studies, promising a safer CAR-T therapy for blood cancers.

HLB Group Unveils Groundbreaking Cancer Treatments at AACR 2026: What You Need to Know

HLB Group will present key findings on anti-cancer therapies at AACR 2026, highlighting SynKIR-110 and Lirafugratinib's advancements.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.